Sarepta Therapeutics announced that the U.S Food and Drug Administration (FDA) has accepted its application for a priority…
Articles by Alejandra Viviescas, PhD
The U.S. Food and Drug Administration (FDA) selected Wave Life Sciences‘ Phase 2/3 trial assessing the efficacy and safety of WVE-210201…
The U.S. Food and Drug Administration has granted orphan drug designation to Myonexus Therapeutics‘ MYO-102, a …
Body mass index (BMI) and blood pressure are modifiable factors that could help to slow heart deterioration in patients with …
Metformin, a diabetes treatment, eased disease progression and improved muscle function in female — and, to a lesser extent, in male…